Literature DB >> 33557407

Impact of Lymphovascular Invasion on Prognosis in the Patients with Bladder Cancer-Comparison of Transurethral Resection and Radical Cystectomy.

Kei Yoneda1,2, Naoto Kamiya1, Takanobu Utsumi1, Ken Wakai2, Ryo Oka1, Takumi Endo1, Masashi Yano1, Nobuyuki Hiruta3, Tomohiko Ichikawa2, Hiroyoshi Suzuki1.   

Abstract

(1) Background: This study aimed to evaluate the associations of lymphovascular invasion (LVI) at first transurethral resection of bladder (TURBT) and radical cystectomy (RC) with survival outcomes, and to evaluate the concordance between LVI at first TURBT and RC. (2)
Methods: We analyzed 216 patients who underwent first TURBT and 64 patients who underwent RC at Toho University Sakura Medical Center. (3)
Results: LVI was identified in 22.7% of patients who underwent first TURBT, and in 32.8% of patients who underwent RC. Univariate analysis identified ≥cT3, metastasis and LVI at first TURBT as factors significantly associated with overall survival (OS) and cancer-specific survival (CSS). Multivariate analysis identified metastasis (hazard ratio (HR) 6.560, p = 0.009) and LVI at first TURBT (HR 9.205, p = 0.003) as significant predictors of CSS. On the other hand, in patients who underwent RC, ≥pT3, presence of G3 and LVI was significantly associated with OS and CSS in univariate analysis. Multivariate analysis identified inclusion of G3 as a significant predictor of OS and CSS. The concordance rate between LVI at first TURBT and RC was 48.0%. Patients with positive results for LVI at first TURBT and RC displayed poorer prognosis than other patients (p < 0.05). (4) Conclusions: We found that the combination of LVI at first TURBT and RC was likely to provide a more significant prognostic factor.

Entities:  

Keywords:  bladder cancer; lymphovascular invasion; neoadjuvant chemotherapy; radical cystectomy; transurethral resection of bladder tumor

Year:  2021        PMID: 33557407      PMCID: PMC7915441          DOI: 10.3390/diagnostics11020244

Source DB:  PubMed          Journal:  Diagnostics (Basel)        ISSN: 2075-4418


  36 in total

Review 1.  The prognostic role of lymphovascular invasion in urothelial carcinoma of the bladder.

Authors:  Romain Mathieu; Ilaria Lucca; Morgan Rouprêt; Alberto Briganti; Shahrokh F Shariat
Journal:  Nat Rev Urol       Date:  2016-07-19       Impact factor: 14.432

2.  Prognostic pathological factors in radical cystectomy after neoadjuvant chemotherapy.

Authors:  Fadi Brimo; Michelle R Downes; Tamara Jamaspishvili; David Berman; Guliz A Barkan; Daniel Athanazio; Schuharazad Abro; Kash Visram; Asli Yilmaz; Shraddha Solanki; Elan Hahn; Robert Siemens; Wassim Kassouf; Kiril Trpkov
Journal:  Histopathology       Date:  2018-08-06       Impact factor: 5.087

3.  EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016.

Authors:  Marko Babjuk; Andreas Böhle; Maximilian Burger; Otakar Capoun; Daniel Cohen; Eva M Compérat; Virginia Hernández; Eero Kaasinen; Joan Palou; Morgan Rouprêt; Bas W G van Rhijn; Shahrokh F Shariat; Viktor Soukup; Richard J Sylvester; Richard Zigeuner
Journal:  Eur Urol       Date:  2016-06-17       Impact factor: 20.096

4.  Accuracy and prognostic value of variant histology and lymphovascular invasion at transurethral resection of bladder.

Authors:  Mohammad Abufaraj; Shahrokh F Shariat; Beat Foerster; Carmen Pozo; Marco Moschini; David D'Andrea; Romain Mathieu; Martin Susani; Anna K Czech; Pierre I Karakiewicz; Veronika Seebacher
Journal:  World J Urol       Date:  2017-11-11       Impact factor: 4.226

Review 5.  A systematic review and meta-analysis of lymphovascular invasion in patients treated with radical cystectomy for bladder cancer.

Authors:  Andrea Mari; Shoji Kimura; Beat Foerster; Mohammad Abufaraj; David D'Andrea; Kilian M Gust; Shahrokh F Shariat
Journal:  Urol Oncol       Date:  2018-04-21       Impact factor: 3.498

6.  Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer.

Authors:  Bernard H Bochner; Michael W Kattan; Kinjal C Vora
Journal:  J Clin Oncol       Date:  2006-07-24       Impact factor: 44.544

7.  The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer.

Authors:  Necole M Streeper; Christopher M Simons; Badrinath R Konety; DeSirae M Muirhead; Richard D Williams; Michael A O'Donnell; Fadi N Joudi
Journal:  BJU Int       Date:  2008-10-06       Impact factor: 5.588

8.  Effectiveness of adjuvant chemotherapy in transitional cell carcinoma of the urinary bladder with lymph node involvement and/or lymphovascular invasion treated by radical cystectomy.

Authors:  Jinsung Park; Sungchan Park; Cheryn Song; Chinkyung Doo; Yong Mee Cho; Hanjong Ahn; Choung-Soo Kim
Journal:  Urology       Date:  2007-08       Impact factor: 2.649

9.  Lymphovascular invasion in transurethral resection specimens as predictor of progression and metastasis in patients with newly diagnosed T1 bladder urothelial cancer.

Authors:  Kang Su Cho; Ho Kyung Seo; Jae Young Joung; Weon Seo Park; Jae Y Ro; Kyung Seok Han; Jinsoo Chung; Kang Hyun Lee
Journal:  J Urol       Date:  2009-10-17       Impact factor: 7.450

10.  Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort.

Authors:  Hans-Martin Fritsche; Maximilian Burger; Robert S Svatek; Claudio Jeldres; Pierre I Karakiewicz; Giacomo Novara; Eila Skinner; Stefan Denzinger; Yves Fradet; Hendrik Isbarn; Patrick J Bastian; Bjoern G Volkmer; Francesco Montorsi; Wassim Kassouf; Derya Tilki; Wolfgang Otto; Umberto Capitanio; Jonathan I Izawa; Vincenzo Ficarra; Seth Lerner; Arthur I Sagalowsky; Mark Schoenberg; Ashish Kamat; Colin P Dinney; Yair Lotan; Shahrokh F Shariat
Journal:  Eur Urol       Date:  2009-09-12       Impact factor: 20.096

View more
  1 in total

1.  Prognostic impact of eligibility for adjuvant immunotherapy in locally advanced urothelial cancer.

Authors:  Yuki Miura; Shingo Hatakeyama; Toshikazu Tanaka; Naoki Fujita; Hirotaka Horiguchi; Yoshiharu Okuyama; Yuta Kojima; Daisuke Noro; Noriko Tokui; Teppei Okamoto; Hayato Yamamoto; Hiroyuki Ito; Takahiro Yoneyama; Yasuhiro Hashimoto; Chikara Ohyama
Journal:  BJUI Compass       Date:  2021-10-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.